feed,title,long_url,short_url
SeekingAlpha,Idera outlines capital requirement to move tilsotolimod toward commercialization in advanced melanoma,https://seekingalpha.com/news/3651250,
SeekingAlpha,GenSight Biologics climbs 9% on publication of results from LUMEVOQ RESCUE Pivotal Phase III Trial,https://seekingalpha.com/news/3651249,
SeekingAlpha,Everest Re Group: Top Tier Reinsurance Play,https://seekingalpha.com/article/4398799,
